Fumi Goshima

Fumi Goshima

UNVERIFIED PROFILE

Are you Fumi Goshima?   Register this Author

Register author
Fumi Goshima

Fumi Goshima

Publications by authors named "Fumi Goshima"

Are you Fumi Goshima?   Register this Author

80Publications

1216Reads

25Profile Views

The BOLF1 gene is necessary for effective Epstein-Barr viral infectivity.

Virology 2019 05 23;531:114-125. Epub 2019 Feb 23.

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Virology and Parasitology, Fujita Health University School of Medicine, Toyoake, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2019.02.015DOI Listing
May 2019

Initial Characterization of the Epstein⁻Barr Virus BSRF1 Gene Product.

Viruses 2019 03 21;11(3). Epub 2019 Mar 21.

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
https://www.mdpi.com/1999-4915/11/3/285
Publisher Site
http://dx.doi.org/10.3390/v11030285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466199PMC
March 2019

Oncolytic Virotherapy by HSV.

Adv Exp Med Biol 2018 ;1045:63-84

Department of Virology, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-10-7230-7_4DOI Listing
November 2018

Differential Day-Night Outcome to HSV-2 Cutaneous Infection.

J Invest Dermatol 2018 01 24;138(1):233-236. Epub 2017 Aug 24.

Department of Dermatology, Faculty of Medicine, University of Yamanashi, Shimokato, Chuo, Yamanashi, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.07.838DOI Listing
January 2018

Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.

J Virol 2017 12 14;91(23). Epub 2017 Nov 14.

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00975-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686753PMC
December 2017

The efficacy of combination therapy with oncolytic herpes simplex virus HF10 and dacarbazine in a mouse melanoma model.

Am J Cancer Res 2017 1;7(8):1693-1703. Epub 2017 Aug 1.

Department of Virology, Nagoya University Graduate School of MedicineNagoya, Japan.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574941PMC
August 2017

The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation.

Sci Rep 2017 07 20;7(1):6044. Epub 2017 Jul 20.

Department of Virology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-06413-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519699PMC
July 2017

Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells.

Oncotarget 2017 Jun;8(24):39345-39355

Department of Virology, Nagoya University Graduate School of Medicine, Showa-Ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16996DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503617PMC
June 2017

The Alarmin IL-33 Derived from HSV-2-Infected Keratinocytes Triggers Mast Cell-Mediated Antiviral Innate Immunity.

J Invest Dermatol 2016 06 9;136(6):1290-1292. Epub 2016 Feb 9.

Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2016.01.030DOI Listing
June 2016

The Epstein-Barr virus BRRF2 gene product is involved in viral progeny production.

Virology 2015 Oct 5;484:33-40. Epub 2015 Jun 5.

Department of Virology, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya 466-8550, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2015.05.010DOI Listing
October 2015

The Epstein-Barr Virus BDLF4 Gene Is Required for Efficient Expression of Viral Late Lytic Genes.

J Virol 2015 Oct 22;89(19):10120-4. Epub 2015 Jul 22.

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01604-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577904PMC
October 2015

Roles of Epstein-Barr virus BGLF3.5 gene and two upstream open reading frames in lytic viral replication in HEK293 cells.

Virology 2015 Sep 15;483:44-53. Epub 2015 May 15.

Department of Virology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00426822150020
Publisher Site
http://dx.doi.org/10.1016/j.virol.2015.04.007DOI Listing
September 2015

Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.

Clin Cancer Res 2014 Oct 12;20(19):5075-84. Epub 2014 Aug 12.

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0580DOI Listing
October 2014

Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation.

Cancer Med 2014 Aug 3;3(4):787-95. Epub 2014 May 3.

Department of Virology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303147PMC
August 2014

Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer.

Int J Cancer 2014 Jun 2;134(12):2865-77. Epub 2013 Dec 2.

Department of Virology, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28631DOI Listing
June 2014

Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production.

J Invest Dermatol 2013 Sep 25;133(9):2170-9. Epub 2013 Mar 25.

Department of Dermatology, University of Yamanashi, Chuo, Yamanashi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2013.150DOI Listing
September 2013

Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models.

Int J Cancer 2013 Apr 26;132(7):1592-601. Epub 2012 Sep 26.

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27823DOI Listing
April 2013

Generation and Characterization of UL21-Null Herpes Simplex Virus Type 1.

Front Microbiol 2012 16;3:394. Epub 2012 Nov 16.

Department of Virology, Nagoya University Graduate School of Medicine Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmicb.2012.00394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499793PMC
November 2012

Diabetic mice show an aggravated course of herpes-simplex virus-induced facial nerve paralysis.

Otol Neurotol 2012 Oct;33(8):1452-7

Department of Otolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences and Medical School, Okazaki, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAO.0b013e318268d54dDOI Listing
October 2012

Apoptosis induction after herpes simplex virus infection differs according to cell type in vivo.

Arch Virol 2010 Aug 11;155(8):1235-45. Epub 2010 Jun 11.

Department of Virology, Graduate School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00705-010-0712
Web Search
http://link.springer.com/10.1007/s00705-010-0712-2
Publisher Site
http://dx.doi.org/10.1007/s00705-010-0712-2DOI Listing
August 2010

Herpes simplex virus UL56 interacts with and regulates the Nedd4-family ubiquitin ligase Itch.

Virol J 2010 Aug 3;7:179. Epub 2010 Aug 3.

Department of Virology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1743-422X-7-179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922189PMC
August 2010

Protective role of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice.

J Virol 2009 Nov 9;83(22):11777-83. Epub 2009 Sep 9.

Division of Host Defense, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01006-09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772681PMC
November 2009

Herpes simplex virus type 2 tegument protein UL56 relocalizes ubiquitin ligase Nedd4 and has a role in transport and/or release of virions.

Virol J 2009 Oct 16;6:168. Epub 2009 Oct 16.

Department of Virology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1743-422X-6-168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770495PMC
October 2009

Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.

J Dermatol Sci 2008 Jun 15;50(3):185-96. Epub 2008 Jan 15.

Department of Dermatology, Aichi Medical University, Nagakute, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdermsci.2007.12.001DOI Listing
June 2008

Herpes simplex virus type 2 UL56 interacts with the ubiquitin ligase Nedd4 and increases its ubiquitination.

J Virol 2008 Jun 19;82(11):5220-33. Epub 2008 Mar 19.

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.02515-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395212PMC
June 2008

Non-engineered, naturally oncolytic herpes simplex virus HSV1 HF-10: applications for cancer gene therapy.

Curr Gene Ther 2008 Jun;8(3):208-21

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156652308784746422DOI Listing
June 2008

Microarray analysis of transcriptional responses to infection by herpes simplex virus types 1 and 2 and their US3-deficient mutants.

Microbes Infect 2008 Apr 9;10(4):405-13. Epub 2008 Jan 9.

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.micinf.2007.12.019DOI Listing
April 2008

A regulatory role of interleukin 15 in wound healing and mucosal infection in mice.

J Leukoc Biol 2008 Jan 28;83(1):165-72. Epub 2007 Sep 28.

Division of Host Defense, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0307137DOI Listing
January 2008

Replication-competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment.

J Gene Med 2007 Oct;9(10):875-83

Department of Virology, Nagoya University Graduate School of Medicine, Tsuruma, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jgm.1085DOI Listing
October 2007

Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide.

Virus Genes 2007 Jun 22;34(3):263-72. Epub 2006 Aug 22.

Department of Virology, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, showa-ku, 466-8550, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11262-006-0013-8DOI Listing
June 2007

[Oncolytic virotherapy using replication-competent herpes simplex viruses].

Uirusu 2007 Jun;57(1):57-65

Department of Virology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2222/jsv.57.57DOI Listing
June 2007

Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus.

Microbes Infect 2007 Feb 12;9(2):142-9. Epub 2006 Dec 12.

Department of Virology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.micinf.2006.10.019DOI Listing
February 2007

Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinoma.

Acta Otolaryngol 2006 Oct;126(10):1115-7

Department of Otorhinolaryngology, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00016480600702100DOI Listing
October 2006

Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancer.

Ann Surg Oncol 2006 Aug 24;13(8):1078-84. Epub 2006 Jul 24.

Department of Surgery II, Graduate School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/ASO.2006.08.035DOI Listing
August 2006

Herpes simplex virus US3 protein kinase regulates virus-induced apoptosis in olfactory and vomeronasal chemosensory neurons in vivo.

Microbes Infect 2006 Jun 27;8(7):1806-12. Epub 2006 Apr 27.

Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.micinf.2006.02.018DOI Listing
June 2006

HF10, an attenuated herpes simplex virus (HSV) type 1 clone, lacks neuroinvasiveness and protects mice against lethal challenge with HSV types 1 and 2.

Microbes Infect 2005 Dec 1;7(15):1492-500. Epub 2005 Jul 1.

Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 480-1195, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.micinf.2005.05.007DOI Listing
December 2005

Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer.

Urology 2005 Nov;66(5):1116-21

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2005.05.041DOI Listing
November 2005

Axonal injury in experimental herpes simplex encephalitis.

Brain Res 2005 Sep;1057(1-2):186-90

Department of Microbiology and Immunology, Aichi Medical University, School of Medicine, Aichi 480-1195, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brainres.2005.07.037DOI Listing
September 2005

US3 protein kinase of herpes simplex virus type 2 is required for the stability of the UL46-encoded tegument protein and its association with virus particles.

J Gen Virol 2005 Jul;86(Pt 7):1979-85

Department of Virology, Nagoya University Graduate School of Medicine, Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1099/vir.0.80949-0DOI Listing
July 2005

Intercellular trafficking activity of herpes simplex virus US11 gene product in the mouse brain.

Brain Res Mol Brain Res 2005 May;136(1-2):158-63

Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Aichi 480-1195, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molbrainres.2005.02.004DOI Listing
May 2005

The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus.

Virology 2005 Mar;334(1):51-8

Department of Microbiology and Immunology, Aichi Medical University School of Medicine, Aichi 480-1195, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2005.01.023DOI Listing
March 2005

Treatment of solid sarcomas in immunocompetent mice with novel, oncolytic herpes simplex viruses.

Otolaryngol Head Neck Surg 2004 Apr;130(4):470-8

Department of Otorhinolaryngology, Graduate School of Medicine, Nagoya University, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.otohns.2004.01.001DOI Listing
April 2004

Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10.

J Surg Oncol 2004 Jan;85(1):42-7

Department of Surgery, Nagoya University School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jso.20005
Publisher Site
http://dx.doi.org/10.1002/jso.20005DOI Listing
January 2004

Herpes simplex virus UL14 protein blocks apoptosis.

Microbiol Immunol 2003 ;47(9):685-9

Laboratory of Virology, Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Nagoya, Aichi 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1348-0421.2003.tb03432.xDOI Listing
December 2003

Iba1-expressing microglia respond to herpes simplex virus infection in the mouse trigeminal ganglion.

Brain Res Mol Brain Res 2003 Dec;120(1):52-6

Department of Microbiology and Immunology, Research Center for Infectious Disease, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molbrainres.2003.10.003DOI Listing
December 2003

The US3 protein kinase of herpes simplex virus attenuates the activation of the c-Jun N-terminal protein kinase signal transduction pathway in infected piriform cortex neurons of C57BL/6 mice.

Neurosci Lett 2003 Nov;351(3):201-5

Department of Microbiology and Immunology, Research Center for Infectious Disease, Aichi Medical University School of Medicine, 21 Karimata, Nagakute-cho, Aichi 480-1195, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2003.08.033DOI Listing
November 2003

Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex viruses.

Hepatogastroenterology 2003 Jul-Aug;50(52):961-6

Laboratory of Virology, Research Institute for Disease, Mechanism and Control, Department of Surgery II, Graduate School of Medicine, Nagoya University, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
October 2003

Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model.

Gynecol Oncol 2003 Oct;91(1):81-8

Department of Gynecology, Aichi Cancer Center Hospital, 1-1 kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0090-8258(03)00417-7DOI Listing
October 2003

Human herpesvirus 6 infection of human epidermal cell line: pathogenesis of skin manifestations.

J Med Virol 2003 Sep;71(1):62-8

Laboratory of Virology, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.10461DOI Listing
September 2003

Phosphorylation of cytokeratin 17 by herpes simplex virus type 2 US3 protein kinase.

Microbiol Immunol 2002 ;46(10):707-19

Laboratory of Virology, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Nagoya, Aichi 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1348-0421.2002.tb02755.xDOI Listing
January 2003

Excretion of herpes simplex virus type 2 glycoprotein D into the culture medium.

J Gen Virol 2002 Nov;83(Pt 11):2791-5

Laboratory of Virology, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Tsurumai-cho, Showa-ku, Japan.

View Article

Download full-text PDF

Source
http://jgv.microbiologyresearch.org/content/journal/jgv/10.1
Publisher Site
http://dx.doi.org/10.1099/0022-1317-83-11-2791DOI Listing
November 2002

Intercellular trafficking of herpes simplex virus type 2 UL14 deletion mutant proteins.

Biochem Biophys Res Commun 2002 Nov;298(3):357-63

Laboratory of Virology, Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0006-291x(02)02452-xDOI Listing
November 2002

Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosis.

J Gen Virol 2002 Sep;83(Pt 9):2109-16

Department of Microbiology, Fukui Medical University School of Medicine, 23-3 Matsuoka-cho, Yoshida-gun, Fukui 910-1193, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1099/0022-1317-83-9-2109DOI Listing
September 2002

Identification and characterization of the UL56 gene product of herpes simplex virus type 2.

J Virol 2002 Jul;76(13):6718-28

Laboratory of Virology, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, 65 Tsumai-cho, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC136277PMC
http://dx.doi.org/10.1128/jvi.76.13.6718-6728.2002DOI Listing
July 2002

Herpes simplex virus type 2 UL14 gene product has heat shock protein (HSP)-like functions.

J Cell Sci 2002 Jun;115(Pt 12):2517-27

Laboratory of Virology, Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Tsurumai-cho 65, Showa-ku, Japan.

View Article

Download full-text PDF

Source
June 2002

Herpes simplex virus type 2 US3 blocks apoptosis induced by sorbitol treatment.

Microbes Infect 2002 Jun;4(7):707-12

Laboratory of Virology, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1286-4579(02)01590-3DOI Listing
June 2002

Identification and characterization of the UL7 gene product of herpes simplex virus type 2.

Virus Genes 2002 Jun;24(3):257-66

Laboratory of Virology, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1015332716927DOI Listing
June 2002

Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis.

J Med Virol 2002 Apr;66(4):497-505

Laboratory of Virology, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
April 2002